Further Evidence That Onabotulinum Toxin Is a Viable Treatment Option for Pediatric Chronic Migraine Patients

Cureus
doi 10.7759/cureus.4343
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Cureus, Inc.

Related search

EHMTI-0037. Botulinum a Toxin for Treatment of Chronic Migraine

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2014English

Bilateral Jaw Dislocation Following Botulinim Toxin Type a Treatment for Chronic Migraine

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2013English

Bilateral Jaw Dislocation Following Botulinim Toxin Type a Treatment for Chronic Migraine

Journal of Headache and Pain
MedicineNeurologyAnesthesiologyPain Medicine
2013English

Fulvestrant: A Further Treatment Option for Patients With Metastatic Uterine Cancer?

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2006English

Is Loop Ileostomy in Patients With Cecal Bascule a Viable Option?

Case Reports in Surgery
2019English

Is Heat Treatment a Viable Option for Destroying Weed Seeds in Biosecurity Risk Goods?

New Zealand Plant Protection
HorticultureInsect ScienceAgronomyCrop Science
2017English

Is Migraine a Risk Factor for Pediatric Stroke?

Cephalalgia
MedicineNeurology
2015English

Radiation Synovectomy: Treatment Option for Haemophilia Patients With Chronic Haemarthrosis: A Review

East African Medical Journal
Medicine
2010English

Review Article: The Evidence That Vancomycin Is a Therapeutic Option for Primary Sclerosing Cholangitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy